PetMed Express Gets Revised $3 Takeover Bid from SilverCape
SilverCape Investments cut its acquisition offer for PetMeds from $4 to $3 per share, the second unsolicited bid in seven months.
PetMed Express confirmed Monday that its board received a second unsolicited, non-binding, and conditional takeover proposal from SilverCape Investments Limited, this time offering $3.00 per share in cash for all outstanding common stock of the Delray Beach, Florida-based online pet pharmacy, which trades on Nasdaq under the ticker PETS.
The revised offer marks a significant step down from SilverCape's previous approach. The investment firm first submitted an unsolicited bid of $4.00 per share on December 11, 2025, making the new $3.00 offer a 25 percent reduction from that earlier proposal — an unusual move in takeover situations, where acquirers typically raise, not lower, their bids over time.
Read more Microsoft AI Segment Hits $37B Run Rate, Fueling 50% Stock Target →
PetMed Express has not disclosed whether its board intends to engage with SilverCape on the revised terms, nor has it set a timeline for a formal response. Because the proposal remains non-binding and conditional, there is no guarantee any transaction will materialize, and the company has made no recommendation to shareholders at this stage.
The downward revision raises questions about SilverCape's valuation calculus and PetMeds' underlying financial health. The company has faced persistent headwinds in the competitive online pet medication market, and a lower bid could reflect deteriorating business fundamentals, changed market conditions, or a negotiating tactic intended to test the board's resolve ahead of further discussions.
Continue reading at GlobalNewswire.
